Cameron McDonald-Hyman is an Oncology physician affiliated with University of Minnesota. OpenAlex indexes 44 publications with 1,390 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
420 Delaware St SE
Minneapolis, MN 554550341
Telephone
612-625-6919Provider last certified this registry record 17 Sept 2024.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BOSTON SCIENTIFIC CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2014–2017 per NIH RePORTER. The latest:
- Modifying Regulatory T-cell signaling to enhance prevention of GVHD
University of Minnesota
FY2017$21,372F30HL121873 - Modifying Regulatory T-cell signaling to enhance prevention of GVHD
University of Minnesota
FY2016$44,374F30HL121873 - Modifying Regulatory T-cell signaling to enhance prevention of GVHD
University of Minnesota
FY2015$36,079F30HL121873
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Acetyl-CoA Carboxylase-1 Inhibition Increases Regulatory T-cell Metabolism and Graft-Vs-Host Disease Treatment Efficacy Via Mitochondrial Fusion
Biology of Blood and Marrow Transplantation
2026 - E7777 to Enhance Regulatory T-cell Depletion Prior to Commercial CAR-T19 for High Risk Diffuse Large B-cell Lymphoma (DLBCL): Results of Phase 1 Trial (NCT0485525) 2477 Characters
Biology of Blood and Marrow Transplantation
2026 - Steroid Refractory GI Acute GVHD Is Associated with Distinct Immune Cell Infiltrates and Gene Expression Profiles
Biology of Blood and Marrow Transplantation
2026 - Clinical Impact of Reduced-Dose Levofloxacin Pre-Engraftment Bacterial Prophylaxis In 3093 Allogeneic and 1719 Autologous Adult and Pediatric HCT Recipients at a Single Institution
Biology of Blood and Marrow Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”